Status:
TERMINATED
Neurostimulation in Chronic and Episodic Migraine
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Kantonsspital Baden
Conditions:
Double-blind Design
Sham-controlled
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Currently, successful prevention of migraine is not sufficiently achieved by (prophylactic) drug therapy. In contrast, neurophysiologically guided treatments might provide an alternative avenue, since...
Eligibility Criteria
Inclusion
- Patients from age 18 upwards (max. 80 years) suffering from chronic or episodic migraine. Medication overuse headache (MOH) patients are included as well (as chronic migraine patients do often show MOH).
- Healthy volunteers (18-80 years) are included if they don't fulfil the exclusion criteria and do not suffer from migraine or other headache disorders, except infrequent episodic tension-type headache All volunteers are able to read and sign the informed consent.
Exclusion
- Patients and healthy volunteers are excluded if they fulfil one of the following exclusion criteria:
- Common MR exclusion criteria: such as metallic items in the body (i.e. eye splinter, MR incompatible implants\*), pacemaker, claustrophobia or obesity (body mass index \> 35).
- Also pregnant participants and participants suffering from a degenerative disorder of the Central Nervous System, such as Stroke, Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease and Huntington's Disease will be excluded. Participants with major psychiatric disorders such as schizophrenia, bipolar disorder will also be excluded.
Key Trial Info
Start Date :
October 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03237754
Start Date
October 1 2016
End Date
May 30 2020
Last Update
August 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091